lobbying_activities: 1988115

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1988115	3256e429-ce0d-4246-9b64-204ca197d884	Q2	ROCK & ASSOCIATES	33545	DIAMONDBACK DRUGS	2017	second_quarter	PHA	Legislation pertaining to pharmacy compounding. H.R. 2871, Patient Access to Compounded Medications Act of 2017.	HOUSE OF REPRESENTATIVES,SENATE	11250		0	0	2017-07-15T11:07:38.350000-04:00